Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 19, 2011Innovative left atrial appendage closure device offers alternative for patients with atrial fibrillation and strengthens Company's position in emerging structural heart markets
Boston Scientific Corporation (NYSE: BSX) today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech,...
-
Jan 10, 2011
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate...
-
Jan 5, 2011Innovative technology designed to advance deep brain stimulation therapy
Boston Scientific Corporation (NYSE: BSX) today announced it has acquired Intelect Medical, Inc., a development-stage company located in...
-
Jan 4, 2011
Boston Scientific Corporation (NYSE: BSX) today issued the following statement from Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm...
-
Jan 4, 2011
Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The...
-
Jan 3, 2011Company prepays $600 million of debt
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of its Neurovascular business to Stryker Corporation. The...
-
Dec 27, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco. Ray...
-
Dec 20, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Kristina M. Johnson, Ph.D., as a...
-
Dec 7, 2010Patients experienced a 50 percent relative reduction in risk of death compared to in-clinic follow-up
Boston Scientific Corporation (NYSE: BSX) today welcomed the publication of an analysis from its ALTITUDE® Clinical Science program in the current issue of
-
Nov 22, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference on December 1 in New York City.
-
Nov 19, 2010Innovative percutaneous aortic valve replacement system provides entry into emerging market of structural heart disease
Boston Scientific Corporation (NYSE: BSX) today announced the signing of a definitive merger agreement, under which...
-
Nov 19, 2010
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its INCEPTA™, ENERGEN™ and PUNCTUA™ cardiac resynchronization...
-
Nov 17, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that its newly acquired subsidiary, Asthmatx, Inc., was awarded the 2010 Popular Science...
-
Nov 11, 2010Company supports efforts of International Diabetes Federation to promote worldwide diabetes education and prevention
Boston Scientific Corporation (NYSE: BSX) today announced its sponsorship of "World Diabetes Day" for the third year in a row. The campaign is led by the...
-
Nov 10, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that it will be hosting an Investor Day meeting, which will be simultaneously...
-
Nov 9, 2010Company implants its first Deep Brain Stimulation device designed to treat Parkinson's
Boston Scientific Corporation (NYSE: BSX) today announced the first implantation of its Vercise™ Deep Brain Stimulation (DBS) System as part...
-
Nov 2, 2010Two-year data presented at CHEST 2010 demonstrate ability of FDA-approved, non-drug asthma treatment to provide long-lasting symptom control
Boston Scientific Corporation (NYSE: BSX) today announced that its newly acquired subsidiary, Asthmatx, Inc., presented two-year...
-
Oct 28, 2010
Boston Scientific Corporation (NYSE: BSX) today announced the execution of a definitive agreement under which Stryker Corporation will acquire...
-
Oct 26, 2010
Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of Asthmatx, Inc. of Sunnyvale, California. The...
-
Oct 22, 2010Company's fully covered metal stent now approved for use in treating benign biliary strictures
Boston Scientific Corporation (NYSE: BSX) today announced that its WallFlex® Biliary RX Fully Covered Stent has received CE Mark approval for the treatment...
-
Oct 21, 2010Latest innovation in plastic biliary stent technology includes features for enhanced deliverability, efficiency and procedural control
Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration and CE...
-
Oct 19, 2010
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2010, as well as guidance for...
-
Oct 13, 2010Major advance in guidewire technology for challenging peripheral interventions
Boston Scientific Corporation (NYSE: BSX) today announced the global launch of its Journey™ Guidewire, an innovative 0.014" guidewire designed for use in...
-
Oct 7, 2010
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30,...
-
Sep 28, 2010MADIT II eight-year outcomes analysis shows that one life is saved for every eight patients who receive an ICD
Boston Scientific Corporation (NYSE: BSX) today welcomed the publication of an analysis of long-term data from the MADIT II clinical trial in the...